NEWMARKET CORP (NEU)
Industrial Organic Chemicals · Healthcare · $7.3B
Intrinsic Value (Consensus)
$609.30
Current Price
$789.88
Margin of Safety
-22.9%
22.9% Above Intrinsic Value
Value: $609
Price: $790
Valuation Model Estimates
Current Price: $789.88
DCF (Discounted Cash Flow)
$677.26
Graham Number
$439.67
Earnings Power Value
$431.46
Relative Value (P/E)
$888.80
Dividend Discount Model
$36.14
Consensus Value
$609.30
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
57
Profitability
22/25
Strength
22/25
Valuation
9/25
Growth
4/25
Financial Health Signals
Declining revenue — top line is shrinking
Strong profitability — ROE of 24% (above 20% is excellent)
Key Financials
- EPS (TTM)
- $44.44
- EPS (Forward)
- $45.33
- Book Value
- $193.33
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 23.5%
- Debt/Equity
- 50%
- Revenue Growth
- -2.2%
- Earnings Growth
- 2.0%
- Dividend Yield
- 0.3%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance